KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Hims & Hers Health (HIMS) Invested Capital (2019 - 2025)

Hims & Hers Health (HIMS) has disclosed Invested Capital for 7 consecutive years, with $544.6 million as the latest value for Q4 2025.

  • Quarterly Invested Capital rose 14.23% to $544.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $544.6 million through Dec 2025, up 14.23% year-over-year, with the annual reading at $544.6 million for FY2025, 14.23% up from the prior year.
  • Invested Capital hit $544.6 million in Q4 2025 for Hims & Hers Health, down from $581.0 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $581.0 million in Q3 2025 to a low of $292.5 million in Q1 2021.
  • Historically, Invested Capital has averaged $392.1 million across 5 years, with a median of $351.7 million in 2023.
  • Biggest five-year swings in Invested Capital: soared 364.7% in 2021 and later dropped 17.41% in 2022.
  • Year by year, Invested Capital stood at $377.5 million in 2021, then decreased by 17.41% to $311.7 million in 2022, then increased by 12.73% to $351.4 million in 2023, then surged by 35.65% to $476.7 million in 2024, then grew by 14.23% to $544.6 million in 2025.
  • Business Quant data shows Invested Capital for HIMS at $544.6 million in Q4 2025, $581.0 million in Q3 2025, and $562.7 million in Q2 2025.